Etirinotecan pegol: an option for late-stage breast cancer?

2 Citations (Scopus)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{9d0b9bcd68344db3b21947f54ec0722f,

title = "Etirinotecan pegol: an option for late-stage breast cancer?",

author = "Nielsen, {Dorte L.} and Nils Br{\"u}nner",

year = "2013",

month = nov,

doi = "10.1016/s1470-2045(13)70441-8",

language = "English",

volume = "14",

pages = "1149--1151",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "TheLancet Publishing Group",

number = "12",

}